| IV-04 Nina Scherer Pharmacokinetic and Pharmacodynamic Modeling of Alirocumab and Evolocumab, two fully human monoclonal antibodies targeting PCSK9 Thursday 14:40-16:00 |
| IV-04 Nina Scherer Pharmacokinetic and Pharmacodynamic Modeling of Alirocumab and Evolocumab, two fully human monoclonal antibodies targeting PCSK9 Thursday 14:40-16:00 |